Drug Dealers | search
Click here to view Drug Dealers news from 60+ newspapers.
Bookmark or Share- Novo inks Ascendis deal to develop long-acting GLP-1, other metabolic ...In addition, Ascendis could receive up to $77.5 million for each additional drug developed. Ascendis has won Food and Drug Administration approval of two products using its extended release technology, both in rare conditions. In partnering with Novo, Ascendis would gain entry into conditions that have blockbuster sales potential.
- Metsera raises $215M to accelerate obesity drug plansThe company’s lead product is a long-acting GLP-1 drug known as MET-097i. In a Phase 1 trial, five weekly injections of the highest dose produced a 7.5% drop in body weight by day 36. At day 57, four weeks after the last dose, the weight loss total rose to 8.1%, suggesting the drug could be given monthly.
- FDA widens use of cancer drug Merck acquired for $1BThe Food and Drug Administration on Thursday broadened use of a drug Merck & Co. acquired in a $1 billion buyout four years ago, clearing Welireg for use in people whose kidney tumors have progressed following treatment with two other types of medicines. Approval was based on a trial that compared Welireg to an older therapy called everolimus ...
- Sarepta rebuilds drug pipeline with Arrowhead dealThe four clinical-stage medicines Sarepta gains via the deal treat diseases of the muscle, central nervous system and lungs. Two are aimed at muscular dystrophies — long the focus of Sarepta’s drug development. The three preclinical assets, meanwhile, are all designed to treat conditions of the central nervous system.
- Novo’s next-gen obesity drug misses expectations in closely watched ...Novo has been looking to it as a way to one-up its key weight loss rival Eli Lilly, whose drug Zepbound helped people lose as much as 21% of their body weight in clinical testing. Unlike Zepbound , which targets two gut hormones with a single drug, cagrisema’s two components are injected separately with a dual-chamber pen device.
More
